Novo Nordisk’s Sogroya receives positive CHMP opinion for pediatric treatment
智通财经2026/09/18 11:01Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Novo Nordisk (NVO.US): Sogroya receives positive CHMP opinion in Europe for pediatric treatment.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Citi: DRAM Shortage May Last Until 2031, SanDisk Shares Surge 8% Intraday
智通财经•2026/09/18 17:06
Volkswagen profit warning drags down European auto stocks; Porsche falls over 5%
智通财经•2026/09/18 15:46
